Cellectar Biosciences Ownership 2024 | Who Owns Cellectar Biosciences Now?
Institutional Ownership
0.00%
Insider Ownership
3.21%
Institutional Holders
1.00
Cellectar Biosciences Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
MENDOTA FINANCIAL GROUP, LLC | - | - | - | -5 | -100.00% | - | Sep 30, 2023 |
Cellectar Biosciences's largest institutional shareholder is MENDOTA FINANCIAL GROUP, LLC, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
MENDOTA FINANCIAL GROUP, LLC | - | - | - | -5 | -100.00% | - | Sep 30, 2023 |
The largest Cellectar Biosciences shareholder by % of total assets is MENDOTA FINANCIAL GROUP, LLC. The company owns 0.00 shares of Cellectar Biosciences (CLRB), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
MENDOTA FINANCIAL GROUP, LLC | - | - | - | -5 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Cellectar Biosciences's largest institutional buyer is MENDOTA FINANCIAL GROUP, LLC. The company purchased -5.00 stocks of CLRB, valued at -.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
MENDOTA FINANCIAL GROUP, LLC | - | - | - | -5 | -100.00% | - | Sep 30, 2023 |
As of Sep 30 2023, Cellectar Biosciences's biggest institutional seller is MENDOTA FINANCIAL GROUP, LLC. The company sold -5.00 shares of CLRB, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
MENDOTA FINANCIAL GROUP, LLC | - | - | - | -5 | -100.00% | - | Sep 30, 2023 |
Cellectar Biosciences's largest sold out institutional shareholder by shares sold is MENDOTA FINANCIAL GROUP, LLC, sold -5.00 shares, valued at -, as of undefined.
Cellectar Biosciences Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
VANGUARD VALLEY FORGE FUNDS | 0.01% | 3,510 | - | - | Mar 31, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 1,650,818 | - | - | Mar 31, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 422,731 | - | - | Feb 29, 2024 |
VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 46,083 | - | - | Mar 31, 2024 |
SCHWAB CAPITAL TRUST | 0.00% | 22,909 | - | - | Feb 29, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 7,984 | - | - | Jan 31, 2024 |
DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 32,146 | - | - | Jan 31, 2024 |
Legg Mason Global Asset Management Trust | 0.00% | 101,244 | - | - | Jan 31, 2024 |
SUNAMERICA SERIES TRUST | 0.00% | 2,400 | - | - | Mar 31, 2024 |
Dimensional ETF Trust | 0.00% | 2,031 | - | - | Jan 31, 2024 |
USAA MUTUAL FUNDS TRUST | 0.00% | 1,012 | - | - | Jan 31, 2024 |
Blackstone Alternative Investment Funds | 0.00% | 10,900 | 10,963 | -17401.59% | Mar 31, 2021 |
EQ ADVISORS TRUST | 0.00% | 3,208 | - | - | Mar 31, 2024 |
iSHARES TRUST | 0.00% | 43,190 | - | - | Mar 31, 2024 |
Legg Mason Global Asset Management Trust | 0.00% | 10,124 | - | - | Jan 31, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 2,568 | - | - | Mar 31, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 377 | - | - | Mar 31, 2024 |
Cellectar Biosciences's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 3.51K shares, compromising 0.01% of its total assets.
Cellectar Biosciences Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
30 Jun, 23 | 1 | - |
31 Mar, 23 | 1 | - |
30 Sep, 22 | 1 | -96.43% |
30 Jun, 22 | 28 | - |
31 Mar, 22 | 28 | -20.00% |
31 Dec, 21 | 35 | - |
30 Sep, 21 | 35 | -14.63% |
30 Jun, 21 | 41 | -2.38% |
31 Mar, 21 | 42 | 13.51% |
31 Dec, 20 | 37 | 94.74% |
30 Sep, 20 | 19 | -9.52% |
30 Jun, 20 | 21 | 40.00% |
31 Mar, 20 | 15 | 50.00% |
31 Dec, 19 | 10 | -16.67% |
30 Sep, 19 | 12 | 20.00% |
30 Jun, 19 | 10 | 11.11% |
31 Mar, 19 | 9 | - |
31 Dec, 18 | 9 | -18.18% |
30 Sep, 18 | 11 | 1000.00% |
30 Jun, 18 | 1 | - |
As of 30 Jun 23, 1 institutions are holding Cellectar Biosciences's shares, representing an increase of 0.00% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
30 Jun, 23 | 5 | - |
31 Mar, 23 | 5 | - |
30 Sep, 22 | 5 | -100.00% |
30 Jun, 22 | 6,561,180 | -3.30% |
31 Mar, 22 | 6,784,960 | 3.48% |
31 Dec, 21 | 6,557,045 | -10.02% |
30 Sep, 21 | 7,287,078 | -41.51% |
30 Jun, 21 | 12,459,505 | -17.09% |
31 Mar, 21 | 15,027,195 | -14.93% |
31 Dec, 20 | 17,664,507 | 411.64% |
30 Sep, 20 | 3,452,550 | 20.44% |
30 Jun, 20 | 2,866,552 | 95.50% |
31 Mar, 20 | 1,466,269 | 13.01% |
31 Dec, 19 | 1,297,481 | -13.86% |
30 Sep, 19 | 1,506,169 | -19.87% |
30 Jun, 19 | 1,879,728 | 661.29% |
31 Mar, 19 | 246,914 | -6.02% |
31 Dec, 18 | 262,722 | -51.50% |
30 Sep, 18 | 541,706 | 648.39% |
30 Jun, 18 | 72,383 | - |
Cellectar Biosciences (CLRB) has 5.00 shares outstanding as of 30 Jun 23, up 0.00% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
30 Jun, 23 | - | - |
31 Mar, 23 | - | - |
30 Sep, 22 | 0.00% | - |
30 Jun, 22 | 107.38% | 0.87% |
31 Mar, 22 | 111.04% | 0.80% |
31 Dec, 21 | 118.11% | 0.80% |
30 Sep, 21 | 121.72% | 0.22% |
30 Jun, 21 | 236.14% | 0.24% |
31 Mar, 21 | 312.16% | 0.23% |
31 Dec, 20 | 366.95% | 2.13% |
30 Sep, 20 | 131.14% | 0.30% |
30 Jun, 20 | 207.82% | 0.85% |
31 Mar, 20 | 156.16% | 0.55% |
31 Dec, 19 | 169.05% | 0.66% |
30 Sep, 19 | 160.46% | 0.22% |
30 Jun, 19 | 269.95% | 10.09% |
31 Mar, 19 | 51.73% | 0.66% |
31 Dec, 18 | 88.70% | 0.31% |
30 Sep, 18 | 170.09% | 9.73% |
30 Jun, 18 | 41.80% | - |
As of 30 Jun 23, Cellectar Biosciences is held by 0.00% institutional shareholders, representing a 0.00% growth compared to 31 Mar 23.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
30 Jun, 23 | - | -100.00% |
31 Mar, 23 | 1 | - |
30 Sep, 22 | - | -100.00% |
30 Jun, 22 | 9 | 28.57% |
31 Mar, 22 | 7 | -50.00% |
31 Dec, 21 | 14 | -17.65% |
30 Sep, 21 | 17 | -34.62% |
30 Jun, 21 | 26 | -3.70% |
31 Mar, 21 | 27 | -10.00% |
31 Dec, 20 | 30 | 233.33% |
30 Sep, 20 | 9 | -30.77% |
30 Jun, 20 | 13 | 85.71% |
31 Mar, 20 | 7 | 75.00% |
31 Dec, 19 | 4 | -20.00% |
30 Sep, 19 | 5 | 25.00% |
30 Jun, 19 | 4 | 100.00% |
31 Mar, 19 | 2 | -50.00% |
31 Dec, 18 | 4 | -63.64% |
30 Sep, 18 | 11 | 1000.00% |
30 Jun, 18 | 1 | - |
- institutional shareholders have increased their position in CLRB stock as of 30 Jun 23 compared to 1 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
30 Jun, 23 | - | - |
31 Mar, 23 | - | - |
30 Sep, 22 | - | -100.00% |
30 Jun, 22 | 6 | 50.00% |
31 Mar, 22 | 4 | -33.33% |
31 Dec, 21 | 6 | 20.00% |
30 Sep, 21 | 5 | - |
30 Jun, 21 | 5 | -16.67% |
31 Mar, 21 | 6 | 200.00% |
31 Dec, 20 | 2 | -60.00% |
30 Sep, 20 | 5 | 150.00% |
30 Jun, 20 | 2 | -33.33% |
31 Mar, 20 | 3 | - |
31 Dec, 19 | 3 | 50.00% |
30 Sep, 19 | 2 | 100.00% |
30 Jun, 19 | 1 | -50.00% |
31 Mar, 19 | 2 | 100.00% |
31 Dec, 18 | 1 | - |
30 Sep, 18 | - | - |
30 Jun, 18 | - | - |
- institutional shareholders have reduced their position in CLRB stock as of 30 Jun 23 compared to - in the previous quarter (a 0.00% increase).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
30 Jun, 23 | 1 | - | 5 | - | - | - | - | -100.00% | - | - |
31 Mar, 23 | 1 | - | 5 | - | - | - | 1 | - | - | - |
30 Sep, 22 | 1 | -96.43% | 5 | -100.00% | 0.00% | - | - | -100.00% | - | -100.00% |
30 Jun, 22 | 28 | - | 6,561,180 | -3.30% | 107.38% | 0.87% | 9 | 28.57% | 6 | 50.00% |
31 Mar, 22 | 28 | -20.00% | 6,784,960 | 3.48% | 111.04% | 0.80% | 7 | -50.00% | 4 | -33.33% |
31 Dec, 21 | 35 | - | 6,557,045 | -10.02% | 118.11% | 0.80% | 14 | -17.65% | 6 | 20.00% |
30 Sep, 21 | 35 | -14.63% | 7,287,078 | -41.51% | 121.72% | 0.22% | 17 | -34.62% | 5 | - |
30 Jun, 21 | 41 | -2.38% | 12,459,505 | -17.09% | 236.14% | 0.24% | 26 | -3.70% | 5 | -16.67% |
31 Mar, 21 | 42 | 13.51% | 15,027,195 | -14.93% | 312.16% | 0.23% | 27 | -10.00% | 6 | 200.00% |
31 Dec, 20 | 37 | 94.74% | 17,664,507 | 411.64% | 366.95% | 2.13% | 30 | 233.33% | 2 | -60.00% |
30 Sep, 20 | 19 | -9.52% | 3,452,550 | 20.44% | 131.14% | 0.30% | 9 | -30.77% | 5 | 150.00% |
30 Jun, 20 | 21 | 40.00% | 2,866,552 | 95.50% | 207.82% | 0.85% | 13 | 85.71% | 2 | -33.33% |
31 Mar, 20 | 15 | 50.00% | 1,466,269 | 13.01% | 156.16% | 0.55% | 7 | 75.00% | 3 | - |
31 Dec, 19 | 10 | -16.67% | 1,297,481 | -13.86% | 169.05% | 0.66% | 4 | -20.00% | 3 | 50.00% |
30 Sep, 19 | 12 | 20.00% | 1,506,169 | -19.87% | 160.46% | 0.22% | 5 | 25.00% | 2 | 100.00% |
30 Jun, 19 | 10 | 11.11% | 1,879,728 | 661.29% | 269.95% | 10.09% | 4 | 100.00% | 1 | -50.00% |
31 Mar, 19 | 9 | - | 246,914 | -6.02% | 51.73% | 0.66% | 2 | -50.00% | 2 | 100.00% |
31 Dec, 18 | 9 | -18.18% | 262,722 | -51.50% | 88.70% | 0.31% | 4 | -63.64% | 1 | - |
30 Sep, 18 | 11 | 1000.00% | 541,706 | 648.39% | 170.09% | 9.73% | 11 | 1000.00% | - | - |
30 Jun, 18 | 1 | - | 72,383 | - | 41.80% | - | 1 | - | - | - |
Cellectar Biosciences Insider Shareholders Trades
Open Market Insider Trades
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Open Market Insider Buys
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
Insider Sells
Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
---|
All Insider Owners Trades
Cellectar Biosciences Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2023 | 5 | - | - |
Q1 2023 | 4 | 1 | 400.00% |
Q4 2022 | 1 | - | - |
Q2 2022 | 5 | - | - |
Q1 2022 | 4 | 1 | 400.00% |
Q3 2021 | 2 | - | - |
Q2 2021 | 5 | - | - |
Q1 2021 | 6 | 5 | 120.00% |
Q4 2020 | 3 | - | - |
Q3 2020 | 1 | 1 | 100.00% |
Q2 2020 | 12 | - | - |
Q1 2020 | 7 | - | - |
Q3 2019 | 1 | - | - |
Q2 2019 | 5 | - | - |
Q1 2019 | 4 | - | - |
Q4 2018 | 12 | 2 | 600.00% |
Q3 2018 | 1 | - | - |
Q2 2018 | 1 | - | - |
Q1 2018 | - | 2 | - |
Q4 2017 | - | 1 | - |
5 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Cellectar Biosciences's insiders, as of Q2 2023.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q2 2023 | - | - | - |
Q1 2023 | - | - | - |
Q4 2022 | - | - | - |
Q2 2022 | - | - | - |
Q1 2022 | - | - | - |
Q3 2021 | 2 | - | - |
Q2 2021 | - | - | - |
Q1 2021 | 1 | 6 | 16.67% |
Q4 2020 | 3 | - | - |
Q3 2020 | - | - | - |
Q2 2020 | 7 | - | - |
Q1 2020 | - | - | - |
Q3 2019 | - | - | - |
Q2 2019 | - | - | - |
Q1 2019 | 1 | - | - |
Q4 2018 | 1 | 4 | 25.00% |
Q3 2018 | 1 | - | - |
Q2 2018 | - | - | - |
Q1 2018 | - | 2 | - |
Q4 2017 | - | 1 | - |
As of Q2 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Cellectar Biosciences's stocks.
Cellectar Biosciences Peer Ownership
Ticker | Company |
---|---|
MNPR | Monopar Therapeutics Inc. |
PULM | Pulmatrix, Inc. |
NXTC | NextCure, Inc. |
BPTH | Bio-Path Holdings, Inc. |
CAPR | Capricor Therapeutics, Inc. |
DFFN | CervoMed Inc. |
TENX | Tenax Therapeutics, Inc. |
BOLT | Bolt Biotherapeutics, Inc. |
CBIO | Gyre Therapeutics, Inc. |
BNTC | Benitec Biopharma Inc. |
ALRN | Aileron Therapeutics, Inc. |
LBPH | Longboard Pharmaceuticals, Inc. |
LUMO | Lumos Pharma, Inc. |
CLRB Ownership FAQ
Who Owns Cellectar Biosciences?
Cellectar Biosciences is owned by institutional shareholders (0%), insiders (3.21%), and public (0%). The largest institutional shareholder of Cellectar Biosciences is MENDOTA FINANCIAL GROUP, LLC (0% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.01% of total shares).
Who are the major institutional shareholders of Cellectar Biosciences?
Cellectar Biosciences's major institutional shareholders are MENDOTA FINANCIAL GROUP, LLC. The top five shareholders own together 0% of the company's share outstanding.
How many Cellectar Biosciences shareholders are there?
As of Jun 2023, there are 1 institutional shareholders of Cellectar Biosciences.
What percentage of Cellectar Biosciences is owned by MENDOTA FINANCIAL GROUP, LLC?
MENDOTA FINANCIAL GROUP, LLC owns 0 shares of Cellectar Biosciences, representing 0% of the company's total shares outstanding, valued at $0 (as of Sep 2023).